FDA Approval: Blinatumomab
Przepiorka, Donna, Ko, Chia-Wen, Deisseroth, Albert, Yancey, Carolyn L, Candau-Chacon, Reyes, Chiu, Haw-Jyh, Gehrke, Brenda J, Gomez-Broughton, Candace, Kane, Robert C, Kirshner, Susan, Mehrotra, Nitin, Ricks, Tiffany K, Schmiel, Deborah, Song, Pengfei, Zhao, Ping, Zhou, Qing, Farrell, Ann T, Pazdur, Richard
Published in Clinical cancer research (15.09.2015)
Published in Clinical cancer research (15.09.2015)
Get full text
Journal Article
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic Syndromes
Kim, Nina, Norsworthy, Kelly J, Subramaniam, Sriram, Chen, Haiyan, Manning, Michael L, Kitabi, Eliford, Earp, Justin, Ehrlich, Lori A, Okusanya, Olanrewaju O, Vallejo, Jonathon, Gehrke, Brenda J, de Claro, R Angelo, Pazdur, Richard
Published in Clinical cancer research (15.08.2022)
Published in Clinical cancer research (15.08.2022)
Get full text
Journal Article
FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation
Woods, Ashley C, Norsworthy, Kelly J, Choe, Moran, Gehrke, Brenda J, Chen, Haiyan, Vallejo, Jonathon, Pan, Lili, Jiang, Xiling, Li, Hongshan, Kraft, Jeffrey, Liu, Jiang, Charlab, Rosane, Okusanya, Olanrewaju O, Booth, Brian, Pazdur, Richard, Theoret, Marc R, de Claro, R Angelo
Published in Clinical cancer research (30.10.2024)
Published in Clinical cancer research (30.10.2024)
Get full text
Journal Article
FDA Approval Summary: Teclistamab - A Bispecific CD3 T-cell Engager for Patients with Relapsed or Refractory Multiple Myeloma
Baines, Andrea C, Kanapuru, Bindu, Zhao, Jay, Price, Lauren S L, Zheng, Nan, Konicki, Robyn, Manning, Michael L, Gehrke, Brenda J, Theoret, Marc R, Gormley, Nicole J
Published in Clinical cancer research (16.10.2024)
Published in Clinical cancer research (16.10.2024)
Get full text
Journal Article
FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation
Pamuk, Gulsum E, Chow, Edwin C Y, Ionan, Alexei C, Chen, Haiyan, Lee, Shwu-Luan, Hsu, Vicky, Grimstein, Manuela, Zheng, Nan, Sun, Jielin, Charlab, Rosane, Gehrke, Brenda J, Vallejo, Jonathon, Ehrlich, Lori A, de Claro, R Angelo, Theoret, Marc R
Published in Clinical cancer research (01.10.2024)
Published in Clinical cancer research (01.10.2024)
Get full text
Journal Article
FDA Approval Summary: Oral Azacitidine for Continued Treatment of Adults with Acute Myeloid Leukemia Unable to Complete Intensive Curative Therapy
Jen, Emily Y, Wang, Xin, Li, Meng, Li, Hongshan, Lee, Shwu-Luan, Ni, Nina, Przepiorka, Donna, Vallejo, Jonathon, Leong, Ruby, Ma, Lian, Gehrke, Brenda J, McLamore, Sherita, Theoret, Marc R, de Claro, R Angelo
Published in Clinical cancer research (15.07.2022)
Published in Clinical cancer research (15.07.2022)
Get full text
Journal Article
Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding
Cortes, Jorge E, Abruzzese, Elisabetta, Cardonick, Elyce H, Hernández-Díaz, Sonia, Gutierrez, Jamie, Sardegna, Mary S, Torres-Chavez, Erica, Dinatale, Miriam, Lerro, Catherine C, Gehrke, Brenda J, Shord, Stacy S, De Claro, R Angelo, Theoret, Marc R, DeMaria, Peter J, Norsworthy, Kelly J
Published in Clinical cancer research (03.09.2024)
Published in Clinical cancer research (03.09.2024)
Get full text
Journal Article
Lobeline does not serve as a reinforcer in rats
HARROD, Steven B, DWOSKIN, Linda P, GREEN, Thomas A, GEHRKE, Brenda J, BARDO, Michael T
Published in Psychopharmacologia (01.02.2003)
Published in Psychopharmacologia (01.02.2003)
Get full text
Journal Article